Novavax
NVAX
$11.16
Share price
0.85%
Change (1 day)
74.68%
Change (1 year)
Categories
Revenue for Novavax (NVAX)
Revenue in 2024 (TTM): A$1.02 Billion
According to Novavax's latest financial reports the company's current revenue (TTM 
) is A$1.06 Billion. an increase over the revenue in the year 2023 that were of A$1.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novavax from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$1.09 B | 7.75% |
| 2023 | A$1.01 B | -50.29% |
| 2022 | A$2.04 B | 29.5% |
| 2021 | A$1.58 B | 155.63% |
| 2020 | A$0.61 B | 2220.49% |
| 2019 | A$26.65 M | -45.24% |
| 2018 | A$48.67 M | 21.88% |
| 2017 | A$39.93 M | 87.49% |
| 2016 | A$21.29 M | -57.2% |
| 2015 | A$49.76 M | 32.83% |
| 2014 | A$37.46 M | 59.78% |
| 2013 | A$23.44 M | 10.37% |
| 2012 | A$21.24 M | 48.3% |
| 2011 | A$14.32 M | 4142.24% |
| 2010 | A$0.33 M | -6.67% |
| 2009 | A$0.36 M | -76.01% |
| 2008 | A$1.5 M | 1.04% |
| 2007 | A$1.49 M | -74.87% |
| 2006 | A$5.94 M | -41.16% |
| 2005 | A$10.09 M | -12.44% |
| 2004 | A$11.53 M | -27.27% |
| 2003 | A$15.85 M | -37.11% |
| 2002 | A$25.21 M | -46.54% |
| 2001 | A$47.15 M | 965.27% |
| 2000 | A$4.42 M | 142.4% |
| 1999 | A$1.82 M | 59.74% |
| 1998 | A$1.14 M | 24.14% |
| 1997 | A$0.92 M | 143.87% |
| 1996 | A$0.37 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | A$0.16 B | -84.83% | 🇺🇸 USA |
 | A$2.97 B | 178.82% | 🇺🇸 USA |
 | A$1.58 B | 48.59% | 🇺🇸 USA |
 | A$0.70 B | -33.93% | 🇺🇸 USA |
 | A$84.61 B | 7,826.71% | 🇬🇧 UK |
 | A$99.56 B | 9,227.11% | 🇺🇸 USA |
 | A$80.93 B | 7,482.07% | 🇨🇭 Switzerland |
 | N/A | N/A | 🇺🇸 USA |
 | A$62.87 B | 5,790.18% | 🇬🇧 UK |
 | A$10.98 M | -98.97% | 🇺🇸 USA |